Subscribe to:
AIDSmeds & POZ newsletters
POZ magazine
Personals Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Hormonally Challenged
Montaner: Treat HIV to Help Curb Infection Spread
Ready to Quit? The Risks and Rewards of a Potent Smoking-Cessation Drug
Zinc Fingers to the Fore
Deep Vein Clotting Risk Higher in HIV
Experimental HIV Drug Hits Snag
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from CancerWEB's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Herpes Simplex Virus
Syphilis & Neurosyphilis
Shingles
The HIV Life Cycle
Human Papilloma Virus (HPV)
Treatments for Opportunistic Infections (OIs)
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

April 8, 2008

Hepatitis B Coinfection Doesn’t Affect HIV Treatment

People with HIV who are coinfected with chronic hepatitis B virus (HBV) respond just as well to antiretroviral (ARV) therapy as people without HBV coinfection, but do have higher death rates, according to a new study published in the May 2008 issue of HIV Medicine.

Previous research has demonstrated that people living with both HIV and HBV may have a more aggressive course of liver disease than HIV-negative people with HBV. What is less understood is whether people who are coinfected with both viruses respond as well to ARV treatment as people with just HIV infection, and whether treating HIV blunts HBV disease progression.

Lars Omland of the Department of Infectious Diseases, Rigshospitalet, in Copenhagen, Denmark, and his colleagues studied the medical records of a large cohort of people living with HIV in Denmark. The study included 3,180 people living with HIV who started ARV treatment between January 1995 and December 2006. Six percent of the participants were also infected with HBV, 87 percent were infected with only HIV, and 7 percent did not have data available to confirm or deny HBV infection and were classified as “unknown.”

Omland’s team found that people who were coinfected with HBV and HIV responded just as well to ARV treatment as people who were infected with just HIV. The two groups had similar CD4 cell increases and sustained control of HIV levels. There were 50 percent more deaths among people who were coinfected, however, and four times as many liver-related deaths.

These study results point to the need to effectively treat not just HIV, but also HBV, in people who are coinfected.


Scroll down to comment on this story.

emailrssprint

Name:

(2-50 characters)

Email:

(will not show)

City:

(optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include either ":" or "@" in your comment.)

| Posting Rules

Previous Comments:

       


[Go to top]

Get Started
Get Answers
I'm HIV positive. What's next?
How to find a support system
Things you should know before starting treatment
How to handle side effects and other concerns
How to tell someone you have HIV/AIDS

Conference Coverage

CROI 2008
Boston, MA
February 3-8, 2008


2007 National Prevention Conference
Atlanta
December 2-7, 2007


11th European AIDS Conference / EACS
Madrid, Spain
October 24-27, 2007


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertise/contact us]

© 2008 Smart + Strong. All Rights Reserved. Terms of use and Your privacy